|Cardiovascular outcomes of sodium-glucose cotransporter 2 inhibitors: a comprehensive review of clinical and preclinical studies|
RK Ghosh, D Bandyopadhyay, A Hajra, M Biswas, A Gupta
International journal of cardiology 212, 29-36, 2016
|Zika virus: a global threat to humanity: a comprehensive review and current developments|
A Hajra, D Bandyopadhyay, SK Hajra
North American journal of medical sciences 8 (3), 123, 2016
|Cardiovascular toxicities of immune checkpoint inhibitors: JACC review topic of the week|
S Ball, RK Ghosh, S Wongsaengsak, D Bandyopadhyay, GC Ghosh, ...
Journal of the American College of Cardiology 74 (13), 1714-1727, 2019
|Safety and efficacy of extremely low LDL-cholesterol levels and its prospects in hyperlipidemia management|
D Bandyopadhyay, A Qureshi, S Ghosh, K Ashish, LR Heise, A Hajra, ...
Journal of Lipids 2018, 2018
|Zika and pregnancy: a comprehensive review|
A Hajra, D Bandyopadhyay, LR Heise, R Bhadra, S Ball, SK Hajra
American Journal of Reproductive Immunology 77 (2), e12607, 2017
|COVID-19 pandemic: cardiovascular complications and future implications|
D Bandyopadhyay, T Akhtar, A Hajra, M Gupta, A Das, S Chakraborty, ...
American Journal of Cardiovascular Drugs, 1-14, 2020
|Hospital complications and causes of 90-day readmissions after implantation of left ventricular assist devices|
B Tripathi, S Arora, V Kumar, K Thakur, S Lahewala, N Patel, M Dave, ...
The American journal of cardiology 122 (3), 420-430, 2018
|Cardiovascular outcomes of PCSK9 inhibitors: with special emphasis on its effect beyond LDL-cholesterol lowering|
D Bandyopadhyay, K Ashish, A Hajra, A Qureshi, RK Ghosh
Journal of lipids 2018, 2018
|Zika virus: New interest in neurology|
A Hajra, D Bandyopadhyay, SK Hajra
Neurology India 64 (5), 1102, 2016
|A study on spectrum of hepatobiliary dysfunctions and pattern of liver involvement in dengue infection|
D Bandyopadhyay, S Chattaraj, A Hajra, S Mukhopadhyay, V Ganesan
Journal of clinical and diagnostic research: JCDR 10 (5), OC21, 2016
|Sodium glucose co-transporter 2 inhibitors and heart failure|
RK Ghosh, GC Ghosh, M Gupta, D Bandyopadhyay, T Akhtar, ...
The American Journal of Cardiology 124 (11), 1790-1796, 2019
|Fish oil and cardiometabolic diseases: recent updates and controversies|
R Tummala, RK Ghosh, V Jain, AR Devanabanda, D Bandyopadhyay, ...
The American journal of medicine 132 (10), 1153-1159, 2019
|Two uncommon causes of Guillain-Barre syndrome: hepatitis E and Japanese encephalitis|
D Bandyopadhyay, V Ganesan, C Choudhury, SS Kar, P Karmakar, ...
Case reports in neurological medicine 2015, 2015
|Cardiac tamponade as initial presentation of Hodgkin lymphoma|
A Hajra, D Bandyopadhyay, M Layek, S Mukhopadhyay
Journal of Clinical Imaging Science 5, 2015
|Trends of cardiac complications in patients with rheumatoid arthritis: analysis of the united states national inpatient sample; 2005-2014|
D Bandyopadhyay, U Banerjee, A Hajra, S Chakraborty, B Amgai, ...
Current problems in cardiology, 100455, 2019
|SGLT-2 Inhibitors and Peripheral Artery Disease: A Statistical Hoax or Reality?|
S Chatterjee, D Bandyopadhyay, RK Ghosh, U Majumdar, A Aneja, ...
Current problems in cardiology 44 (7), 207-222, 2019
|Effectiveness and Safety of Inclisiran, A Novel Long-Acting RNA Therapeutic Inhibitor of Proprotein Convertase Subtilisin/Kexin 9|
GC Ghosh, D Bandyopadhyay, RK Ghosh, S Mondal, E Herzog
The American journal of cardiology 122 (7), 1272-1277, 2018
|An update on pharmacotherapies in diabetic dyslipidemia|
M Gupta, R Tummala, RK Ghosh, C Blumenthal, K Philip, ...
Progress in cardiovascular diseases 62 (4), 334-341, 2019
|Comparison of treatment options for depression in heart failure: A network meta-analysis|
A Das, B Roy, G Schwarzer, MG Silverman, O Ziegler, D Bandyopadhyay, ...
Journal of psychiatric research 108, 7-23, 2019
|New hope for hyperlipidemia management: Inclisiran|
D Bandyopadhyay, A Hajra, K Ashish, A Qureshi, S Ball
Journal of Cardiology 71 (5), 523-524, 2018